Live feed07:00:00·1655dPRReleasevia QuantisnowAgios Announces Data from Investigator-led Studies of Mitapivat in Adults with Sickle Cell Disease Demonstrating Improvements in Anemia, Hemolysis and Sickling Parameters at 63rd ASH Annual Meeting and ExpositionByQuantisnow·Wall Street's wire, on your screen.AGIO· Agios Pharmaceuticals Inc.Health Care
